Aroa Biosurgery narrows loss, boosts Myriad sales as sheep stomach tech pays off

Aroa Biosurgery narrows loss, boosts Myriad sales as sheep stomach tech pays off
Aroa Biosurgery founder Brian Ward says new clinical publications should further validate the efficacy of its products. (Image: Aroa Biosurgery)
Rebecca Stevenson
Soft tissue regeneration company Aroa Biosurgery has boosted revenue and narrowed its loss. The Auckland-based company announced its result for the six months to Sept 30 on Tuesday. The ASX-listed firm said revenue increased 14% to $44.9 million, with revenue from its Myriad products rising 33% on the same period in the prior financial year to $19.7m. Aroa uses sheep stomachs to create wound repair products, including for complex wound treatment. Its proprietary soft tissue extracellular matrix helps to encourage human tissu...

More Markets

Contact sets out aggressive growth push
Markets

Contact sets out aggressive growth push

Contact is relying on demand increase to fund expansion.

FIF tax creator says ‘sorry’, but wants deeper reform
Policy

FIF tax creator says ‘sorry’, but wants deeper reform

Economist Peter Wilson says the Government's FIF changes need to go further.

The ‘evolution’ in Synlait Milk’s strategy
Primary Sector

The ‘evolution’ in Synlait Milk’s strategy

It’s going to return to being a South Island processor.